Advertisment Nexovas Cilnidipine
Indian Journal of Nephrology About us |  Subscription |  e-Alerts  | Feedback | Login   
  Print this page Email this page   Small font sizeDefault font sizeIncrease font size
 Home | Current Issue | Archives| Ahead of print | Search |Instructions |  Editorial Board  

Users Online:1441

Official publication of the Indian Society of Nephrology
 ~   Next article
 ~   Previous article
 ~   Table of Contents

 ~   Similar in PUBMED
 ~  Search Pubmed for
 ~  Search in Google Scholar for
 ~Related articles
 ~   Citation Manager
 ~   Access Statistics
 ~   Reader Comments
 ~   Email Alert *
 ~   Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed919    
    Printed28    
    Emailed0    
    PDF Downloaded89    
    Comments [Add]    

Recommend this journal

 

 REVIEW
Year : 2018  |  Volume : 28  |  Issue : 4  |  Page : 257-264

Fluoroquinolones and BK virus nephropathy: A myth or a reality


1 Diaverum Prince Abdul Majeed Renal Centre, Jeddah, Saudi Arabia
2 Department of Urology, Institute of Kidney Disease, Peshawar, KPK, Pakistan
3 Department Nephrology, RIPAS Hospital, Bander Seri Begawan, Brunei Darussalam
4 Department of Nephrology and Transplantation, King Salman Armed Forces Hospital, Tabuk, Saudi Arabia

Correspondence Address:
M. A. M Khalil
Diaverum Prince Abdul Majeed Renal Centre, Jeddah
Saudi Arabia
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/ijn.IJN_251_17

Rights and Permissions

BK polyomavirus (BKV) is a challenging problem for the transplant nephrologist. Various strategies have been used to prevent or treat BK virus nephropathy (BKVN). These include reduction in immunosuppression, intravenous immune globulin, cidofovir, leflunomide, and the fluoroquinolone antibiotics. All these agents have their own toxicities. Great interest was shown to use fluoroquinolones to prevent BKVN after its useful experience was reported in bone marrow transplant. Fluoroquinolones being cheap and easily available, attracted nephrologists to use it, for prevention of BKVN. These agents have been shown in vitro studies to be effective. However, there are mixed results about their effectiveness in prevention of BKVN in clinical setting. This review will focus the evidence available for using fluoroquinolones in prevention of BKVN and its usefulness. Furthermore, a way forward to use these agents or not for prevention of BKVN will also be discussed.






[FULL TEXT] [PDF]*


        
Print this article     Email this article

Indian Journal of Nephrology
Published by Wolters Kluwer - Medknow
Online since 20th Sept '07